Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.07
UNIS's Cash to Debt is ranked lower than
54% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.07 vs. UNIS: 0.07 )
UNIS' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.07

Equity to Asset -0.03
UNIS's Equity to Asset is ranked lower than
54% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. UNIS: -0.03 )
UNIS' s 10-Year Equity to Asset Range
Min: -0.03   Max: 0.79
Current: -0.03

-0.03
0.79
F-Score: 3
Z-Score: -5.34
M-Score: -3.62
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -462.02
UNIS's Operating margin (%) is ranked lower than
55% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. UNIS: -462.02 )
UNIS' s 10-Year Operating margin (%) Range
Min: -2225.96   Max: -235.51
Current: -462.02

-2225.96
-235.51
Net-margin (%) -534.99
UNIS's Net-margin (%) is ranked lower than
55% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.99 vs. UNIS: -534.99 )
UNIS' s 10-Year Net-margin (%) Range
Min: -2303.97   Max: 276.17
Current: -534.99

-2303.97
276.17
ROE (%) -383.78
UNIS's ROE (%) is ranked lower than
55% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. UNIS: -383.78 )
UNIS' s 10-Year ROE (%) Range
Min: -277.5   Max: 47.29
Current: -383.78

-277.5
47.29
ROA (%) -85.14
UNIS's ROA (%) is ranked lower than
54% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. UNIS: -85.14 )
UNIS' s 10-Year ROA (%) Range
Min: -83.87   Max: 33.39
Current: -85.14

-83.87
33.39
ROC (Joel Greenblatt) (%) -118.78
UNIS's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. UNIS: -118.78 )
UNIS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -345.48   Max: -94.75
Current: -118.78

-345.48
-94.75
Revenue Growth (%) 10.90
UNIS's Revenue Growth (%) is ranked higher than
86% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. UNIS: 10.90 )
UNIS' s 10-Year Revenue Growth (%) Range
Min: -50   Max: 76.5
Current: 10.9

-50
76.5
EBITDA Growth (%) -9.80
UNIS's EBITDA Growth (%) is ranked higher than
62% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. UNIS: -9.80 )
UNIS' s 10-Year EBITDA Growth (%) Range
Min: -9.8   Max: 152
Current: -9.8

-9.8
152
EPS Growth (%) -5.50
UNIS's EPS Growth (%) is ranked higher than
65% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. UNIS: -5.50 )
UNIS' s 10-Year EPS Growth (%) Range
Min: -5.5   Max: 239.1
Current: -5.5

-5.5
239.1
» UNIS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

UNIS Guru Trades in Q4 2013

Jim Simons 291,121 sh (New)
Paul Tudor Jones 16,021 sh (New)
» More
Q1 2014

UNIS Guru Trades in Q1 2014

Paul Tudor Jones Sold Out
Jim Simons Sold Out
» More
Q2 2014

UNIS Guru Trades in Q2 2014

Jim Simons 319,845 sh (New)
» More
Q3 2014

UNIS Guru Trades in Q3 2014

Jim Simons 277,940 sh (-13.1%)
» More
» Details

Insider Trades

Latest Guru Trades with UNIS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 25.80
UNIS's P/S is ranked lower than
52% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. UNIS: 25.80 )
UNIS' s 10-Year P/S Range
Min: 16.07   Max: 86.25
Current: 25.8

16.07
86.25
EV-to-EBIT -6.48
UNIS's EV-to-EBIT is ranked lower than
51% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.42 vs. UNIS: -6.48 )
UNIS' s 10-Year EV-to-EBIT Range
Min: -11.6   Max: -3.2
Current: -6.48

-11.6
-3.2
Current Ratio 1.04
UNIS's Current Ratio is ranked lower than
52% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. UNIS: 1.04 )
UNIS' s 10-Year Current Ratio Range
Min: 0.69   Max: 8.01
Current: 1.04

0.69
8.01
Quick Ratio 1.03
UNIS's Quick Ratio is ranked higher than
53% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. UNIS: 1.03 )
UNIS' s 10-Year Quick Ratio Range
Min: 0.68   Max: 7.77
Current: 1.03

0.68
7.77

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.63
UNIS's Price/Median PS Value is ranked higher than
94% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.19 vs. UNIS: 0.63 )
UNIS' s 10-Year Price/Median PS Value Range
Min: 0.47   Max: 1.94
Current: 0.63

0.47
1.94
Earnings Yield (Greenblatt) -15.40
UNIS's Earnings Yield (Greenblatt) is ranked higher than
52% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. UNIS: -15.40 )
UNIS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -15.4

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 31
Jun15 Jun16
Revenue(Mil)
EPS($) -0.12 0.18
EPS without NRI($) -0.12 0.18

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:UNS.Australia, UNISZ.USA, 4UL.Germany,
Unilife Corporation Limited, formerly Unilife Medical Solutions Limited is an US-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Target customers include pharmaceutical manufacturers, suppliers of medical equipment, healthcare facilities and patients who self-administer prescription medication. Unilife is ISO 13485-certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.
» More Articles for UNIS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 28 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 28 2012 
Medical. All insider Jan 24 2012 
Weekly CEO Buys Highlight: TRNO, UNIS, GFN Jan 21 2012 
Weekly CEO Buys Highlight: UNIS, TRNO, WINA, SXC, CTFO Jan 14 2012 
3.31 Jan 12 2012 
Recent Purchase Jan 08 2012 

More From Other Websites
Unilife Hires Intel Marketing Executive Kevin Sellers as Senior Vice President of Marketing and... Dec 11 2014
Unilife Signs Long-Term Commercial Supply Agreement for Use of Depot-ject™ Delivery System with... Dec 02 2014
UNILIFE CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 02 2014
Unilife Signs Long-Term Commercial Supply Agreement for Use of Depot-ject™ Delivery System with... Dec 02 2014
Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd Nov 25 2014
UNILIFE CORP Financials Nov 19 2014
UNILIFE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Nov 19 2014
10-Q for Unilife Corp. Nov 14 2014
UNILIFE CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 14 2014
Unilife and Flextronics Enter Into Global Strategic Alliance Nov 13 2014
Unilife and Flextronics Enter Into Global Strategic Alliance Nov 13 2014
UNILIFE CORP Files SEC form 10-Q, Quarterly Report Nov 12 2014
Midday Losers From November 11: Vivint Solar, Unilife, Wayfair, Rayonier, Halcon Resources Nov 11 2014
Unilife Corporation Submits its 10-Q for Filing Nov 11 2014
Unilife Corporation Submits its 10-Q for Filing Nov 11 2014
Unilife beats 1Q profit forecasts Nov 11 2014
Unilife beats 1Q profit forecasts Nov 11 2014
/C O R R E C T I O N -- Unilife Corporation/ Nov 10 2014
Q1 2015 Unilife Corp Earnings Release - After Market Close Nov 10 2014
Should You Buy Unilife Corporation (UNIS) Ahead of Earnings? Nov 07 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK